AbClon Inc. (KOSDAQ:174900)
South Korea · Delayed Price · Currency is KRW 24,600
-950 (-3.72%)
Oct 12, 2026, 3:30 PM KST
AbClon Market Cap
AbClon has a market cap or net worth of 490.82 billion as of October 12, 2026. It is the 16,788th most valuable company in the world and the 475th biggest in South Korea. Its market cap has increased by 41.64% in one year.
Market Cap
490.82B
Enterprise Value
462.18B
Revenue
5.31B
Global Rank
Country Rank
#475 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2017, AbClon's market cap has increased from 176.80B to 490.82B, an increase of 177.61%. That is a compound annual growth rate of 11.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 490.82B | -39.57% |
| Dec 30, 2025 | 812.27B | 230.14% |
| Dec 30, 2024 | 246.04B | 6.90% |
| Dec 28, 2023 | 230.16B | 17.39% |
| Dec 29, 2022 | 196.07B | -27.49% |
| Dec 30, 2021 | 270.42B | -48.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmicell | 771.65B |
| Chabiotech | 758.52B |
| Onconic Therapeutics | 675.21B |
| Hyundai Bioscience | 668.77B |
| GI Innovation | 545.81B |
| Proteina | 489.96B |
| GC Corp. | 443.05B |
| Medy-Tox | 425.60B |